Virginia Society of Health-System Pharmacists

NOMINATION AND ELECTION OF VIRGINIA DELEGATES TO THE ASHP HOUSE OF DELEGATES

All pharmacist ASHP members in Virginia are eligible to nominate, be nominated, and vote for delegates and alternates to represent Virginia at the American Society of Health-System Pharmacists (ASHP) 2021 House of Delegates. 

Individuals wishing to nominate themselves or another ASHP member for the slate of candidates are invited to submit names by email, by 5pm, December 18, 2020, to: Steve Glass (contact@vshp.org) Executive Director.   Nominations must be accompanied with a bio not to exceed 300 words.

Two (2) delegates and up to two (2) alternate delegates will be elected.

The House of Delegates will meet in person on two separate occasions at the 2021 ASHP Summer Meetings in Long Beach, CA from June 6-8, 2021.

Additionally, there may be virtual House meetings in 2021 as needed

The candidate receiving the most votes will become delegate, with the next highest vote receivers  elected as alternates.  A simple majority is required for election. 

For further information, please contact the VSHP office at (850) 906-0779 or email contact@vshp.org .

The ASHP Task Force on Racial Diversity, Equity, and Inclusion invite ASHP members to participate in an important member survey. The purpose of the survey is to collect feedback on the preliminary recommendations from the ASHP Task Force on Racial Diversity, Equity, and Inclusion. Please review the following information and then use the link below to access the survey which should take 15-20 minutes of your time to complete.

Follow this link to the Survey:  Recommendations Feedback

Or copy and paste the URL into your internet browser: http://ashp.az1.qualtrics.com/jfe/form/SV_cVlZG58aKizkpbn?Q_DL=N3VcqY8mZkgoXsl_cVlZG58aKizkpbn_MLRP_cNLs8KJjPiZECfH&Q_CHL=email

ASHP and its members have long been committed to eliminating racial and ethnic disparities in healthcare and recognize the need to further strengthen that commitment following the killings of George Floyd, Ahmaud Arbery, Breonna Taylor, and other Black Americans. ASHP further seeks to help eliminate racism, discrimination, and inequities that impact other minority and underrepresented populations and to help improve diversity, equity, and inclusion in healthcare and society more broadly.

While the Task Force developed the preliminary recommendations with a specific focus on Black Americans, the Task Force members believe that many of the recommendations should also support other communities of color. In order to reflect more inclusive language within its recommendations, the Task Force decided to use the term “Black, Indigenous, and People of Color,” also referred to as BIPOC throughout the recommendations. Mental Health America (MHA) considers the following communities as BIPOC: Black/African American, Latinx/Hispanic American, Asian American/Pacific Islander, Native and Indigenous, and Multiracial.

The deadline for this survey is December 10, 2020. Please be assured that your responses will be anonymous. The Task Force plans to review comments and prepare a final report and recommendations to the ASHP Board of Directors in January 2021.

Thank you in advance for your time and support.

Sincerely,


Paul C. Walker, Pharm.D., FASHP
Task Force Chair and ASHP Board Liaison

Congratulations to Kathy Koehl-VSHP 2020 Pharmacist of the Year

https://vimeo.com/478623070

https://vimeo.com/478623070

Congratulations to Tyler Sledge-VSHP 2020 Clinical Pharmacy Practice Achievement Award

https://vimeo.com/478619418

Congratulations to Khalida Amini-VSHP 2020 New Practitioner of the Year

https://vimeo.com/478613847

Congratulations to Jessica Franklin-2020 VSHP Technician of the Year

https://vimeo.com/478548559https://vimeo.com/478548559

https://www.ashp.org/News/2020/10/26/ASHP-Past-President-R-David-Anderson-Reflects-on-His-First-95-Years

Congratulations to Carrie Carter, Lark Dunton, Emily Hand and Sarah Wheeler winners of our 2020 Trivia Contest during Pharmacy Week

National Women Pharmacist Day

Effective October 1, 2020, Veklury (remdesivir) will no longer be allocated by the U.S. Department of Health and Human Services (HHS), the Office of the Assistant Secretary for Preparedness and Response (ASPR) and State Departments of Health. This change is possible given that there is now sufficient supply of Veklury (remdesivir) to meet demand, even if a surge of COVID-19 cases occurs.

See additional information:  AmerisourceBergen Remdesivir Distribution.pdf